Search results for: Health Policy and Regulation
Filter search results
Personalised Medicine: Is it an Oil-Rush or Oil-Spill?
3 February 2020, 12:00am
…im Geshundheitswesen (IQWiG)), as well as for a number of international bodies (including the World Bank, the WHO and the IMF) and pharmaceutical companies and health care insurance companies (including…
International Drug Pricing Transparency
20 July 2020, 11:00pm
…on drug pricing regulation and negotiation in many countries, most notably in the US, are challenging this view and the issue of price transparency poses an existential threat to innovation…
The Impact of Biosimilars on Markets
24 May 2010
…regulatory experts in the US and Europe were invited to describe their research and offer their perspectives about what can be expected in the near- and medium-term. The presentations and discussion:…
Value Based Pricing in the UK
7 September 2010
…by a voluntary agreement, renewed and revised periodically, between the government and the pharmaceutical industry, the Pharmaceutical Price Regulation Scheme (PPRS). Prior to the last round of negotiations, the Office…
Access to Orphan Drugs in the EU
21 October 2010
…are available, diagnostic systems are suboptimal, and very few health care professionals are trained in the diagnosis and treatment of each rare disease. OHE’s research shows that requirements and practice…
Update: Value-Based Pricing in the UK
11 January 2011
…Paper on health reform, ‘Equity and excellence: Liberating the NHS’. In December, 2010 the Department of Health (DH) published a consultation document on VBP — ‘A new value-based approach to…
OHE is Seeking Two Economists
12 July 2011
…a good first degree, majoring in economics a postgraduate qualification and practical experience in applied econometrics or/and industrial economics interest in, and understanding of, policy related to health care systems…
New: 50 Years of OHE Publications Are Available Online
2 April 2012
…the basic questions have changed very little. Particularly important changes that have occurred over the fifty years include, for example, the appearance and now-routine use of health economics and health…
Spotlight on OHE: Understanding Value Based Pricing
12 February 2013
…health care systems and the role of patients’ groups that was organised by Roche and EGAN, the Patients’ Network for Medical Research and Health, which is an alliance of European patients’…